Baraniuk J, Eaton-Fitch N, Marshall-Gradisnik S
Front Immunol. 2024; 15:1440643.
PMID: 39483457
PMC: 11524851.
DOI: 10.3389/fimmu.2024.1440643.
Ramiller A, Mudie K, Seibert E, Whittaker S
JMIR Res Protoc. 2022; 11(8):e36798.
PMID: 35816681
PMC: 9369615.
DOI: 10.2196/36798.
Aoun Sebaiti M, Hainselin M, Gounden Y, Sirbu C, Sekulic S, Lorusso L
Sci Rep. 2022; 12(1):2157.
PMID: 35140252
PMC: 8828740.
DOI: 10.1038/s41598-021-04764-w.
Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W
J Transl Med. 2020; 18(1):365.
PMID: 32972442
PMC: 7512220.
DOI: 10.1186/s12967-020-02533-3.
Ghali A, Lacout C, Ghali M, Gury A, Beucher A, Lozach P
Sci Rep. 2019; 9(1):18817.
PMID: 31827223
PMC: 6906377.
DOI: 10.1038/s41598-019-55473-4.
Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S
Front Immunol. 2019; 10:2545.
PMID: 31736966
PMC: 6834647.
DOI: 10.3389/fimmu.2019.02545.
Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Sweetman E, Noble A, Edgar C, Mackay A, Helliwell A, Vallings R
Diagnostics (Basel). 2019; 9(3).
PMID: 31295930
PMC: 6787691.
DOI: 10.3390/diagnostics9030073.
Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H, Muraki K, Balinas C, Eaton-Fitch N, Staines D, Marshall-Gradisnik S
Mol Med. 2019; 25(1):14.
PMID: 31014226
PMC: 6480905.
DOI: 10.1186/s10020-019-0083-4.
Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S
Mol Med. 2018; 24(1):44.
PMID: 30134818
PMC: 6092868.
DOI: 10.1186/s10020-018-0046-1.
A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review.
Teodoro T, Edwards M, Isaacs J
J Neurol Neurosurg Psychiatry. 2018; 89(12):1308-1319.
PMID: 29735513
PMC: 6288708.
DOI: 10.1136/jnnp-2017-317823.
Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik S
BMC Pharmacol Toxicol. 2018; 19(1):12.
PMID: 29587879
PMC: 5870391.
DOI: 10.1186/s40360-018-0203-8.
Natural killer cells in patients with severe chronic fatigue syndrome.
Brenu E, Hardcastle S, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K
Auto Immun Highlights. 2015; 4(3):69-80.
PMID: 26000145
PMC: 4389023.
DOI: 10.1007/s13317-013-0051-x.
Systematic review of the multidimensional fatigue symptom inventory-short form.
Donovan K, Stein K, Lee M, Leach C, Ilozumba O, Jacobsen P
Support Care Cancer. 2014; 23(1):191-212.
PMID: 25142703
DOI: 10.1007/s00520-014-2389-7.
The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
Twisk F
Front Physiol. 2014; 5:109.
PMID: 24734022
PMC: 3974331.
DOI: 10.3389/fphys.2014.00109.
Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome.
Lattie E, Antoni M, Fletcher M, Penedo F, Czaja S, Lopez C
Brain Behav Immun. 2012; 26(6):849-58.
PMID: 22417946
PMC: 3572196.
DOI: 10.1016/j.bbi.2012.02.008.
The Fatigue Symptom Inventory: a systematic review of its psychometric properties.
Donovan K, Jacobsen P
Support Care Cancer. 2010; 19(2):169-85.
PMID: 20824482
DOI: 10.1007/s00520-010-0989-4.
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
Fletcher M, Zeng X, Maher K, Levis S, Hurwitz B, Antoni M
PLoS One. 2010; 5(5):e10817.
PMID: 20520837
PMC: 2876037.
DOI: 10.1371/journal.pone.0010817.
A formal analysis of cytokine networks in chronic fatigue syndrome.
Broderick G, Fuite J, Kreitz A, Vernon S, Klimas N, Fletcher M
Brain Behav Immun. 2010; 24(7):1209-17.
PMID: 20447453
PMC: 2939140.
DOI: 10.1016/j.bbi.2010.04.012.
Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.
White A, Light A, Hughen R, Bateman L, Martins T, Hill H
Psychophysiology. 2010; 47(4):615-24.
PMID: 20230500
PMC: 4378647.
DOI: 10.1111/j.1469-8986.2010.00978.x.
Polysaccharide of radix pseudostellariae improves chronic fatigue syndrome induced by poly I:C in mice.
Sheng R, Xu X, Tang Q, Bian D, Li Y, Qian C
Evid Based Complement Alternat Med. 2009; 2011:840516.
PMID: 20008077
PMC: 3137695.
DOI: 10.1093/ecam/nep208.